Latest news on Laboratorytalk categorised by supplier
Argenta Discovery
Address:
8/9 Spire Green Centre
Flex Meadow
Harlow
CM19 5TR
UK
Telephone: (UK) +44 1279 645645
http://www.argentadiscovery.com
Our RSS feed for news from Argenta Discovery
Request to receive our free email newsletter each week
Listing of all 14 news releases from Argenta Discovery:
Trial of potential new therapy for COPD
Argenta Discovery has initiated a Phase II clinical trial with ADC4022 for the treatment of chronic obstructive pulmonary disease (COPD) and steroid-insensitive asthma
News from Argenta Discovery (26 February 2008)
Electrophysiology and hERG screening from Argenta
Argenta Discovery has entered into an alliance with NeuroSolutions to gain preferential access to its specialist electrophysiology and hERG testing services and expertise.
News from Argenta Discovery ( 8 January 2008)
Extension to Genentech drug discovery deal
Argenta Discovery, a pharmaceutical R+D group, has extended its integrated contract drug discovery agreement with Genentech for a further two-year period
News from Argenta Discovery ( 9 November 2007)
Argenta Discovery announces new collaboration
Argenta Discovery has announced that it has entered into a drug discovery collaboration with AstraZeneca LP.
News from Argenta Discovery (26 July 2006)
Argenta in collaboration with PainCeptor Pharma
Argenta Discovery, a contract and respiratory drug development company, announced that it has entered into a development collaboration with PainCeptor Pharma
News from Argenta Discovery ( 2 May 2006)
Argenta strenthens senior management team
Respiratory drug development and contract drug discovery company strengthens management team with the appointment of John Montana as chief scientific officer and Chris Moyses as chief medical officer
News from Argenta Discovery (24 February 2006)
Dr Reddy and Argenta in R+D collaboration
Dr Reddy Laboratories and Argenta Discovery in agreement for the joint development and commercialisation of a novel approach to the treatment of chronic obstructive pulmonary disease (COPD)
News from Argenta Discovery (10 February 2006)
Two year drug discovery agreement with Novartis
Up to 18 Argenta scientists will work on the Novartis programme, which centres on the search for new diabetes therapies
News from Argenta Discovery (25 January 2006)
Two year drug discovery agreement with Genentech
Argenta Discovery, a contract drug discovery and respiratory drug development company, has entered into a two-year drug discovery collaboration with Genentech
News from Argenta Discovery (16 December 2005)
Argenta in drug discovery agreement with Cellzome
Argenta will apply its integrated medicinal chemistry, assay development and screening capabilities and collaborate with Cellzome's scientists in the search for new disease therapies
News from Argenta Discovery (30 August 2005)
Domain antibody products treat respiratory disease
Domantis and Argenta Discovery to co-develop domain antibody products to treat respiratory disease - partnership combines domain antibodies with expertise in COPD and other lung diseases
News from Argenta Discovery (27 October 2004)
Seeking to mitigate migraine
Pharmagene and Argenta Discovery have announced an agreement to identify new chemical entities to interact with a 7-TM receptor target to develop migraine treatment candidates
News from Argenta Discovery (14 November 2001)
Sykes opens Argenta laboratories
New research laboratories of independent medicinal chemistry company Argenta Discovery were opened by Sir Richard Sykes, chairman of GlaxoSmithKline and rector of Imperial College
News from Argenta Discovery ( 2 November 2001)
Collaborating to control pain
Adolor Corporation, the US-based biopharmaceutical company, has recently engaged Argenta Discovery to seek out new potential drug candidates in the field of pain management
News from Argenta Discovery (19 October 2001)
